NCT05253040

Brief Summary

Parkinson's Disease (PD) is a progressive neurological condition that affects movement, balance and cognition, resulting in loss of independence and compromised quality of life over the course of the condition. Research suggests that those detrimental outcomes can be reduced through physical activity (PA) and exercise, especially when those are started early. Educating people with Parkinson's (PwP) on the role of PA and exercise in PD progression can boost PA engagement by increasing enablers such as exercise self-efficacy and removing barriers such as misinformation about exercise and exercise outcomes. Working closely with PwP and healthcare professionals, a physical health education programme was co-designed to address the needs and preferences of PwP around exercise and PA education. The process was supervised by the patient and Public Involvement group attended by PwP, academics, researchers and clinicians working with PwP. The study will utilise an assessor blinded randomised controlled design to investigate the acceptability and feasibility of delivering an online physical health education programme for PwP who are newly diagnosed. Thirty PwP, diagnosed in the last 12-months, will be randomly allocated into two groups: 1) the intervention group in which participants will receive online education modules and will be invited to attend virtual group sessions with a specialist neuro-physiotherapist; 2) the control group which will follow the usual care pathway and participants will receive Parkinson's UK booklets. The aim of the study is to explore an alternative approach to standard care regarding patient education in PD and evaluate the feasibility and acceptability of a co-designed education intervention for newly diagnosed PwP delivered online. Feasibility data will be collected during the study and acceptability data will be assessed via a questionnaire at the end. Outcomes including PA levels, exercise knowledge, exercise efficacy, and participation will be assessed at baseline, post-intervention and at 6 months.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 23, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

June 18, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 21, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 18, 2023

Completed
Last Updated

November 4, 2022

Status Verified

November 1, 2022

Enrollment Period

3 months

First QC Date

February 2, 2022

Last Update Submit

November 1, 2022

Conditions

Keywords

Physical activityeducationexerciseself-efficacy

Outcome Measures

Primary Outcomes (5)

  • Acceptability assessment 1: Recruitment rate

    Assessment of recruitment rate of study (% of eligible participants enrolled)

    Through study completion (12 months)

  • Acceptability assessment 2: Education programme compliance

    Compliance with the online education programme (% of sessions completed)

    Through study completion (12 months)

  • Acceptability assessment 3: Drop out rate

    Comparison of drop out rates (%) between the intervention group and control group

    Through study completion (12 months)

  • Acceptability assessment 4: Acceptability of Intervention

    A questionnaire designed to assess satisfaction with the education intervention. it includes multiple choice and open ended questions.

    Completed at the end of participation in the study (after 8 weeks)

  • Feasibility of delivering the intervention online

    Assessment of any technical problems or difficulties accessing online intervention as reported by participants

    Through study completion (12 months)

Secondary Outcomes (11)

  • Unified Parkinson's Disease Rating Scale Part 3

    Baseline(week 0) and follow up (6-month post intervention)

  • MiniBESTest

    Baseline(week 0) and follow up (6-month post intervention)

  • Five time Sit To Stand

    Baseline(week 0) and follow up (6-month post intervention)

  • Self-efficacy for Exercise

    Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)

  • Hospital Anxiety and Depression Scale

    Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)

  • +6 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

The experimental group will receive: Online education modules Online group discussions facilitated by Specialist Physiotherapist

Other: KEEP Intervention

Control Group

ACTIVE COMPARATOR

The comparator for this study is usual care pathway. Under the usual care pathway, participants will receive education booklets on exercise by Parkinson's UK.

Other: control

Interventions

Educational intervention

Intervention group
controlOTHER

booklet from Parkinson's UK

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of Idiopathic Parkinson's Disease
  • Within 12 months since diagnosis
  • Stable medication regime for four weeks prior to initiation of trial
  • Ability to understand written English

You may not qualify if:

  • Acute illness
  • History of neurological disorder other than Parkinson Disease
  • Diagnosis of dementia or significant cognitive impairments
  • Participation in NHS structured PD-specific education program with or without exercise classes in the last year
  • Unable to understand written English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychiatry

Cambridge, CB2 0SZ, United Kingdom

Location

Related Publications (1)

  • Agley L, Hartley P, Duffill D, Iqbal A, Mackett A, Rennie KL, Lafortune L. Digital Intervention Promoting Physical Activity in People Newly Diagnosed with Parkinson's Disease: Feasibility and Acceptability of the Knowledge, Exercise-Efficacy and Participation (KEEP) Intervention. J Parkinsons Dis. 2024;14(6):1193-1210. doi: 10.3233/JPD-240071.

MeSH Terms

Conditions

Parkinson DiseaseMotor Activity

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

February 2, 2022

First Posted

February 23, 2022

Study Start

June 18, 2022

Primary Completion

September 21, 2022

Study Completion

June 18, 2023

Last Updated

November 4, 2022

Record last verified: 2022-11

Locations